Business Context and Reporting Period
Company: Radiopharm Theranostics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2025
Date of Filing: August 21, 2025
Principal Executive Office: Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia
This filing serves to disclose a public announcement made to the Australian Securities Exchange (ASX) regarding the Company's plan to host a key opinion leader webinar series.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This Form 6-K is a disclosure of a corporate announcement and does not contain financial statements or quantitative financial data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document. The filing focuses solely on the upcoming operational activity of hosting a webinar series.
Guidance, Outlook, and Management Commentary
- Corporate Activity: The Company announced it will host a key opinion leader webinar series.
- Outlook: No specific financial guidance or strategic outlook was provided in this filing.
- Risks and Contingencies: No specific risks or contingencies were detailed in this report.
Investor Verification Checklist
- Verify the date and content of the attached ASX announcement (Exhibit 99.1) regarding the webinar series.
- Confirm if the webinar series impacts the Company's clinical trial timelines or commercialization strategy.
- Review subsequent filings for any financial impact resulting from this engagement activity.